Long-Term Outcome After Annular Mechanical Mitral Valve Replacement in Children Aged Less Than Five Years

2010 ◽  
Vol 90 (5) ◽  
pp. 1570-1576 ◽  
Author(s):  
Roland Henaine ◽  
Joseph Nloga ◽  
Fabrice Wautot ◽  
Naoki Yoshimura ◽  
Muriel Rabilloud ◽  
...  
2017 ◽  
Vol 5 (4) ◽  
pp. 454-457
Author(s):  
Go Kataoka ◽  
Kiyoharu Nakano ◽  
Ryota Asano ◽  
Atsuhiko Sato ◽  
Wataru Tatsuishi

2003 ◽  
Vol 76 (3) ◽  
pp. 853-859 ◽  
Author(s):  
Brian K Eble ◽  
William P Fiser ◽  
Pippa Simpson ◽  
Judith Dugan ◽  
Jonathan J Drummond-Webb ◽  
...  

2019 ◽  
Vol 14 (1) ◽  
Author(s):  
Ayse Cetinkaya ◽  
Julia Poggenpohl ◽  
Karin Bramlage ◽  
Stefan Hein ◽  
Mirko Doss ◽  
...  

1998 ◽  
Vol 6 (3) ◽  
pp. 174-178
Author(s):  
Mustafa Emir ◽  
Gürkan Uzunonat ◽  
Birol Yamak ◽  
A Tulga Ulus ◽  
M Kamil Göl ◽  
...  

Between 1986 and 1990, 304 females between 11 and 45 (mean, 33.9 ± 6.9) years of age underwent isolated mitral valve replacement with a bioprosthesis. Thirty-nine of the 285 survivors experienced 48 pregnancies during the late follow-up period (group 1). Structural valve deterioration occurred in 25 (64.1%) of these patients and in 70 (28.4%) of the 246 patients (group 2) who did not become pregnant (p < 0.01). The mean time at which structural valve deterioration occurred was 7.01 ± 1.19 years postoperatively (range, 4.74 to 8.36 years) for group 1 patients and 6.76 ± 1.34 years (range, 2.33 to 10.17 years) for group 2 patients (p > 0.05). Freedom from structural valve deterioration at 10 years was 22.9% ± 8.11% for group 1 and 29.24% ± 6.09% for group 2 (p > 0.05). We concluded that pregnancy did not influence the long-term outcome after mitral valve replacement with a bioprosthesis.


Perfusion ◽  
2021 ◽  
pp. 026765912110032
Author(s):  
Tamer Abdalghafoor ◽  
Hatem Sarhan ◽  
Ali Kindawi

Introduction: Mitral regurgitation (MR) is defined as an abnormal reversal of blood flow from the left ventricle to the left atrium (LA). It is caused by disruption in any part of the mitral valve apparatus. Surgical intervention remains the mainstay of management for severe cases. Case summary: We are reporting a case of pneumonia with severe sepsis, that had a complicated hospital course. The patient developed multi-organ failure. Echocardiography on admission showed severe mitral regurgitation. He required early mechanical ventilation and then Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) over 29 days. He might be the first case of Coronavirus Disease 2019 (COVID-19) in our hospital. Mitral valve replacement was done after stabilization of the patient and weaning from the ECMO. Discussion: Our report demonstrates that the use of a long term VV-ECMO as a bridge for stabilization, facilitates management of the critically ill respiratory failure patient with severe MR and patient outcomes. Still the long-term results and the optimal timing of intervention need more research to define. Conclusion: Our report demonstrates that the use of a long term VV ECMO facilitates management of patients with respiratory failure associated with severe MR. Future studies focusing on stabilizing such patients, might help to define the optimal timing for intervention in these patients and the long-term outcome.


2021 ◽  
Vol 30 ◽  
pp. S21-S22
Author(s):  
K.F.L. Lee ◽  
O.J.O.J. Lee ◽  
T.L.D. Chan ◽  
K.L.C. Ho ◽  
W.K.T. Au

Circulation ◽  
1999 ◽  
Vol 100 (Supplement 2) ◽  
pp. II-48-II-53 ◽  
Author(s):  
J. Turina ◽  
T. Stark ◽  
B. Seifert ◽  
M. Turina

Sign in / Sign up

Export Citation Format

Share Document